KIORA PHARMACEUTICALS, INC. Finance Lease, Liability, Current
KIORA PHARMACEUTICALS, INC. (KPRX) had Finance Lease, Liability, Current of $2.50 thousand as of 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2021-11-15
- 2021-03-31: Finance Lease, Liability, Current $2.50K.
- 2020-12-31: Finance Lease, Liability, Current $1.82K.
- 2018-12-31: Finance Lease, Liability, Current $4.71K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2021-03-31 | $2.50K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.82K 10-Q · filed 2021-11-15 |
| 2018-12-31 | $4.71K 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |